Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN)

Price 10,794.00p on 20-01-2025 at 17:30:00
Change -144.00p -1.32%
Buy 10,816.00p
Sell 10,812.00p
Buy / Sell AZN Shares
Last Trade: Sell 934.00 at 10,794.00p
Day's Volume: 1,013,396
Last Close: 10,794.00p
Open: 10,942.00p
ISIN: GB0009895292
Day's Range 10,794.00p - 10,984.00p
52wk Range: 9,461.00p - 13,338.00p
Market Capitalisation: £167,366m
VWAP: 10,847.43011p
Shares in Issue: 1,551m

Recent Trades History Astrazeneca (AZN)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 934 10,794.00p SI Trade
Suspected SELL Trade
16:49:08 - 20-Jan-25
Sell* 196 10,794.00p Automatic Execution
16:38:19 - 20-Jan-25
Sell* 16 10,794.00p Automatic Execution
16:38:06 - 20-Jan-25
Buy* 800 10,829.555p SI Trade
Negotiated Trade
16:35:28 - 20-Jan-25
Sell* 27 10,794.00p Automatic Execution
16:35:03 - 20-Jan-25
Sell* 141 10,794.00p SI Trade
16:35:00 - 20-Jan-25
Unknown* 348 10,794.00p OTC Trade
16:35:00 - 20-Jan-25
Unknown* 2 10,794.00p OTC Trade
16:35:00 - 20-Jan-25
Sell* 443,382 10,794.00p Uncrossing Trade
16:35:00 - 20-Jan-25
Buy* 2 10,816.00p Automatic Execution
16:29:57 - 20-Jan-25

Share Price History for Astrazeneca

Time period:
to
Date Open High Low Close Volume

Share News for Astrazeneca

LONDON BROKER RATINGS: Jefferies raises Spirax; Peel Hunt cuts Grainger

20th Jan 2025 09:56

(Alliance News) - The following London-listed shares received analyst recommendations on Monday morning and on Friday: Read More

AstraZeneca and Daiichi's Datroway wins US FDA breast cancer approval

20th Jan 2025 08:38

(Alliance News) - AstraZeneca PLC on Monday said Datroway has been approved in the US for patients with a type of breast cancer. Read More

LONDON BRIEFING: Stocks down; BT's Openreach unveils network expansion

20th Jan 2025 07:56

(Alliance News) - The FTSE 100 was called to open down on Monday morning, ahead of Donald Trump's first day as 47th US president. Read More

AstraZeneca's Calquence gets US approval for mantle cell lymphoma

17th Jan 2025 08:16

(Alliance News) - AstraZeneca PLC on Friday said its drug Calquence, in combination with chemoimmunotherapy, has received approval from the US Food & Drug Administration for the treatment of adult patients with previously untreated mantle cell lymphoma who are ineligible for stem cell transplantation. Read More

LONDON BRIEFING: Stocks called up but UK retail sales miss forecasts

17th Jan 2025 07:48

(Alliance News) - Stocks were called to open higher on Friday after China recorded one of its slowest rates of economic growth in decades last year, despite outperforming consensus in the fourth quarter. Read More

FTSE 100 Latest
Value8,520.54
Change15.32

Login to your account

Forgot Password?

Not Registered